In the last trading session, 1.28 million NovoCure Ltd (NASDAQ:NVCR) shares changed hands as the company’s beta touched 0.62. With the company’s per share price at $15.55 changed hands at $0.77 or 5.21% during last session, the market valuation stood at $1.67B. NVCR’s last price was a discount, traded about -437.62% off its 52-week high of $83.60. The share price had its 52-week low at $10.87, which suggests the last value was 30.1% up since then. When we look at NovoCure Ltd’s average trading volume, we note the 3-month average coming to 1.29 million.

NovoCure Ltd (NASDAQ:NVCR) trade information

Instantly NVCR was in green as seen at the end of in last trading. With action 21.48%, the performance over the past five days has been green. The jump to weekly highs of 15.75 added 5.21% to the stock’s daily price. The company’s shares are showing year-to-date upside of 4.15%, with the 5-day performance at 21.48% in the green. However, in the 30-day time frame, NovoCure Ltd (NASDAQ:NVCR) is 13.17% up.

NovoCure Ltd (NVCR) estimates and forecasts

Data shows that the NovoCure Ltd share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 14.84% over the past 6 months, a 8.72% in annual growth rate that is considerably lower than the industry average of 12.50%. Year-over-year growth is forecast to reach 7.10% up from the last financial year.

Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 134.76M. 7 analysts are of the opinion that NovoCure Ltd’s revenue for the current quarter will be 136.78M. The estimates for the next quarter sales put growth at 7.40%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -22.97%. The 2024 estimates are for NovoCure Ltd earnings to increase by 15.90%.